JPRN-UMIN000011910已完成未知
Feasibility study of adjuvant chemotherapy with carboplatin and nab-paclitaxel for resected NSCLC - Feasibility study of adjuvant chemotherapy with carboplatin and nab-paclitaxel for resected NSCLC
Division of Respiratory Medicine, Department of Internal Medicine,Kobe University Graduate School of Medicine0 个研究点目标入组 21 人开始时间: 2013年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)The patient with infection (2)The patient with fever (equal to or more than 38 C) (3)The patient with heavy complication (4)The patient with active double-cancer (5)The patient with uncontrolled pleural effuson (6)The patient with a motor-palsy or figure of peripheral-nerve-disease (7)The patient with drug hypersensitivity (8)The patient with common use of NSAIDs (9)The expectant mother, the woman who has a lactating-woman and the possibility of the pregnancy (10)The patient judged as unsuitable by the doctor
研究者
相似试验
招募中
2 期
Phase II Study of neoadjuvant chemotherapy with carboplatin,pemetrexed and bevacizumab in patients with non-squemous non-small-cell lung canceron-squamous,non-small-cell lung cancerJPRN-UMIN000006759niversity of Tsukuba, Faculty of Medicine, Department of Thoracic Surgery30
已完成
不适用
Feasibility study of adjuvant chemotherapy with cisplatin and pemetrexed short hydration regimen for completely resected NSCLCCompletely resected NSCLC(non-squamous cell carcinoma, stage II - IIIA)JPRN-UMIN000010336Division of Respiratory Medicine, Department of Internal Medicine,Kobe University Graduate School of Medicine21
进行中（未招募）
1 期
Feasibility study of adjuvant chemotherapy with cisplatin(CDDP) and TS-1 in followed by alternate-day treatment with TS-1 in patients with completely resected pathological II-IIIA non small cell lung cancerJPRN-jRCTs071180083Suzuki Makoto58
招募中
不适用
Feasibility study of adjuvant chemotherapy with cisplatin(CDDP) and TS-1 in followed by alternate-day treatment with TS-1 in patients with completely resected pathological II-IIIA non small cell lung canceron-small cell lung cancerJPRN-UMIN000011345Department of Thoracic Surgery , Faculty of Life Science Kumamoto University58
已完成
2 期
Feasibility study of adjuvant chemotherapy with combination Docetaxel AND Daily Oral Cyclophosphamide for Japanese breast cancer patients.Breast CancerJPRN-UMIN000006673Shiga University of Medical Science20